Sensex Rises Over 200 Points, Nifty Trades Above 17,600
The Indian equity benchmarks on Wednesday rose in opening deals, tracking a positive trend in global markets. Asian shares traded in the green boosted by U.S. inflation figures that fared better than markets' worst expectations. Trends on the Nifty Futures on Singapore Exchange (SGX Nifty) also indicated a gap-up start for the domestic indices.
U.S. monthly consumer prices increased by the most in 16-1/2 years in March. However, monthly underlying inflation pressures moderated as goods prices, excluding food and energy, dropped by the most in two years.
Back home, the 30-share BSE Sensex jumped 238 points or 0.41 per cent to 58,814 in early trade, while the broader NSE Nifty moved 74 points or 0.42 per cent up to 17,604.
Mid- and small-cap shares were trading on a strong note as Nifty Midcap 100 gained 0.82 per cent and small-cap shares surged 1.07 per cent.
All the 15 sector gauges -- compiled by the National Stock Exchange -- were trading in the green. Nifty Metal and Nifty FMCG were outperforming the index by rising as much as 0.70 per cent and 1.39 per cent, respectively.
On the stock-specific front, JSW Steel was the top gainer as the stock soared 3.06 per cent to Rs 779. ONGC, Tata Steel, Apollo Hospitals and UPL were also among the gainers.
The overall market breadth stood strong as 1,164 shares were advancing while 369 were declining on BSE.
On the 30-share BSE index, Tata Steel, Hindustan Unilever, Bharti Airtel, Bajaj Finance, Reliance Industries, L&T, M&M and ITC were among the top performers.
In contrast, Titan, Asian Paints and Dr Reddy's were trading in the red.
Sensex had tanked 388 points or 0.66 per cent to close at 58,576 on Tuesday, while Nifty had moved 145 points or 0.82 per cent lower to settle at 17,530.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.